| abstract |
Compounds that have a structural spin characteristics are described herein. Methods for making these compounds, methods for using these compounds in order to modulate the activity of nuclear steroid hormone receptors, and pharmaceutical compositions and medicaments comprising such compounds are also described herein. Methods for using the compounds, pharmaceutical compositions and medicaments for treating and / or preventing diseases or conditions associated with the activity of nuclear steroid hormone receptors are also described herein. |